Home
Quiver Bioscience

Quiver Bioscience Market Share Analysis for May 2026

Quiver Bioscience was built to create transformational medicines for patients living with disorders of the brain. Utilizing human disease models, novel AI, and best-in-world platform, we stand as the premier partner in the journey from target discovery to the clinic.

Industry: N/A

Domainquiverbioscience.com

Year Founded2013

Employees51 - 200

Annual Revenue--

Quiver Bioscience

Quiver Bioscience (including company regionals)

quiverbioscience.com

See more website traffic and engagement information

Total visits to Quiver Bioscience's top domains

Understand Quiver Bioscience market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

quiverbioscience.com2K

See more with Sales Intelligence

Avg. visit duration in Quiver Bioscience's top domains

Analyze Quiver Bioscience engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

quiverbioscience.com00:00:38

See more with Sales Intelligence

Avg. pageviews on Quiver Bioscience's top domains

See how Quiver Bioscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

quiverbioscience.com1.96

See more with Sales Intelligence

Quiver Bioscience top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Quiver Bioscience

These are the website technologies, by industry, used by Quiver Bioscience top domains

Email Services (3)

G Suite

Content Management System (1)

WebFlow

Conversion & Analytics (1)

Google Analytics

Marketing (1)

Google Marketing Platform

More Technologies

4

See all

News & Signals from Quiver Bioscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsQuiver Bioscience partners with Boston Children’s Hospital.Quiver is collaborating with Boston Children's Hospital to validate QV-2421's functional activity in sensory neurons derived from patients with erythromelalgia and small fiber neuropathy, two rare neuropathic pain conditions with limited treatment options.

NewsQuiver Bioscience integrates with Angelini Pharma.The collaboration, which also includes a licensing agreement, brings together Quiver's drug discovery capabilities, data assets and AI models with Angelini Pharma's expertise in brain health and epilepsy drug development.